Kevin Fitzgerald
Chief Tech/Sci/R&D Officer chez ALNYLAM PHARMACEUTICALS, INC.
Fortune : 2 M $ au 31/03/2024
Postes actifs de Kevin Fitzgerald
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2016 | - |
| Corporate Officer/Principal | 01/01/2005 | 01/09/2016 | |
| OVID THERAPEUTICS INC. | Director/Board Member | 06/10/2021 | - |
| Independent Dir/Board Member | 06/10/2021 | - |
Historique de carrière de Kevin Fitzgerald
Formation de Kevin Fitzgerald
| Cornell University | Undergraduate Degree |
| Princeton University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| OVID THERAPEUTICS INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
- Bourse
- Insiders
- Kevin Fitzgerald
- Expérience
